ViaCyte

ViaCyte is a California-based regenerative medicine company that develops and commercializes cell replacement therapies for the treatment of diabetes.

Business Model:

Revenue: $25M

Employees: 51-200

Detailed ViaCyte Information

ViaCyte was acquired by Vertex Pharmaceuticals.
The acquisition happend on 2022-07-11.
Details of the transaction were not public

Geographic Data

ViaCyte headquarters map

Address: 5580 Morehouse Drive

City: San Diego

State: CA

Zip: 92121

Country: US

Financial Info

Stage:

series d

Raised Last:

$0

Raised Total:

$221M

Metrics

2,258,022Website Global Rank

8,451Website Monthly Traffic

Twitter Followers

Description

ViaCyte is a California-based regenerative medicine company that develops and commercializes cell replacement therapies for the treatment of diabetes.

Contact Phone:
+18582070500

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2014 Grant 1 $16.6M California Institute for Regenerative Medicine
5/2017 Venture Round $0 JDRF (The Juvenile Diabetes Research Foundation)
W.L. Gore &a; Associates
Asset Management Partners
JDRF (The Juvenile Diabetes Research Foundation)
W.L. Gore &a; Associates
Asset Management Partners
12/2017 Grant 1 $1.4M California Institute for Regenerative Medicine
California Institute for Regenerative Medicine
5/2000 Series B -
7/2007 Series C $0 Asset Management Ventures (AMV)
Johnson &a; Johnson Development Corporation
Pacific Horizon Ventures
Sanderling Ventures
Asset Management Ventures (AMV)
Johnson &a; Johnson Development Corporation
Pacific Horizon Ventures
Sanderling Ventures
5/2006 Venture Round $0 Asset Management Ventures (AMV)
BD Venture
DFJ Portage Ventures
Headland Ventures
Johnson &a; Johnson Development Corporation
Pacific Horizon Ventures
Sanderling Ventures
The Vertical Group
Asset Management Ventures (AMV)
BD Venture
DFJ Portage Ventures
Headland Ventures
Johnson &a; Johnson Development Corporation
Pacific Horizon Ventures
Sanderling Ventures
The Vertical Group
8/2014 Series C $5.4M
7/2013 Series C 2 $10.6M Sanderling Ventures
Johnson &a; Johnson Development Corporation
Sanderling Ventures
Johnson &a; Johnson Development Corporation
11/2018 Series D $0 Bain Capital Life Sciences
TPG
RA Capital Management
Sanderling Ventures
Bain Capital Life Sciences
Bain Capital Life Sciences
TPG
RA Capital Management
Sanderling Ventures
Bain Capital Life Sciences
9/2018 Convertible Note 1 $10M W.L. Gore &a; Associates
W.L. Gore &a; Associates
W.L. Gore &a; Associates
W.L. Gore &a; Associates
4/2021 Series D $45M Adage Capital Partners
Invus Group
Asymmetry Ventures
Artis Ventures
Bain Capital Life Sciences
TPG Capital
RA Capital Management
Sanderling Ventures
8/2014 Venture Round 1 $20M Johnson &a; Johnson Innovation
Johnson &a; Johnson Innovation
4/2018 Grant -
4/2018 Grant 1 - National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
7/2016 Grant $3.9M
3/2020 Series D $0 Bain Capital Life Sciences
RA Capital Management
Sanderling Ventures
TPG Capital Asia
Bain Capital Life Sciences
RA Capital Management
Sanderling Ventures
TPG Capital Asia
4/2021 Series D 1 - Asymmetry Ventures
Asymmetry Ventures
3/2020 Series D 4 $32.6M Bain Capital Life Sciences
TPG Capital
RA Capital Management
Sanderling Ventures
Bain Capital Life Sciences
RA Capital Management
Sanderling Ventures
TPG Capital Asia
11/2018 Series D 4 $80M Bain Capital Life Sciences
RA Capital Management
TPG Capital Management
Sanderling Ventures
Bain Capital Life Sciences
TPG
RA Capital Management
Sanderling Ventures
Bain Capital Life Sciences
4/2018 Grant - National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
5/2017 Equity 3 $10M Asset Management Partners
W.L. Gore & Associates, Inc
JDRF
4/2021 Series D 1 - Asymmetry Ventures
Asymmetry Ventures
4/2018 Grant 1 - National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research